Aurora Cannabis (NYSE: ACB) needs to improve its performance this year. The stock is down more than 65% in the first four months of 2020; it's performing much worse than the Horizons Marijuana Life Sciences ETF (OTC: HMLSF), which has declined by just 28%. The company needs a way to rally investors, and there's no better way to do so than by improving on its financials; the pot producer's recorded an operating loss in every one of its past 10 quarterly results. Read More...
Why Aurora Cannabis Should Reduce Its Global Footprint, Too
Aurora Cannabis (NYSE: ACB) needs to improve its performance this year. The stock is down more than 65% in the first four months of 2020; it’s performing much worse than the Horizons Marijuana Life Sciences ETF (OTC: HMLSF), which has declined by just 28%. The company needs a way to rally investors, and there’s no better way to do so than by improving on its financials; the pot producer’s recorded an operating loss in every one of its past 10 quarterly results.
Add Comment